Omar Alhalabi

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Omar Alhalabi
Dec 26, 2024, 14:42 | Science
Tanya Jindal: Biomarkers associated with response to EV monotherapy in patients with Advanced Urothelial Carcinoma
Tanya Jindal, Physician Scientist at Interested in GU Oncology, shared a recent article on X:…
Dec 24, 2024, 14:29 | Drugs
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X: “Advanced urothelial carcinoma…
Dec 23, 2024, 13:21 | Insight
Emanuele Crupi: Antiangiogenic Therapy Combined with Immune Checkpoint Blockade in Urothelial Cancer
Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn…
Dec 23, 2024, 13:06 | Blog
Omar Alhalabi: Analysis of UNITE Study Data
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Hot-off-press. Genomic…
Dec 22, 2024, 11:44 | Insight
Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X:…
Dec 22, 2024, 11:22 | Insight
Omar Alhalabi: Antiangiogenesis and immune checkpoint blockade in urothelial cancer
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared an X: “Hot-off-press anti…
Dec 19, 2024, 14:08 | Blog
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared on X: "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer…
Nov 9, 2024, 19:37 | Blog
Omar Alhalabi: Advancing Knowledge on Aggressive Bladder Cancer Subtypes
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared an X: “Hot off…
Oct 3, 2024, 13:00 | Positive
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
September was a significant month dedicated to raising awareness about various cancers, and Prostate Cancer…
Sep 2, 2024, 07:25 | Blog
Mohammad Jad Moussa: Thrilled to share my selection as a top recipient of the Trainee Abstract Competition for TxSCO2024
Mohammad Jad Moussa, MD Anderson Cancer Center shared a post on X: "Thrilled to Share…
Jul 19, 2024, 14:41 | Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Jun 15, 2024, 05:45 | Blog
Mohammad Jad Moussa: Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
Jun 8, 2024, 05:20 | Insight
Mohammad Jad Moussa: ASCO24 Proceedings - GTA as a Nephron-Sparing 'Bridging' Strategy
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
Jun 5, 2024, 10:46 | Blog
Mohammad Jad showcased work on small cell neuroendocrine carcinomas at ASCO24 - MD Anderson Cancer Center
Mohammad Jad Moussa, GU Oncologist at MD Anderson Cancer Center, shared a post by MD…
May 30, 2024, 03:50 | Blog
Pavlos Msaouel: Tremendously enjoyed this podcast as the clip shows
Amanda Nizam, GU Medical Oncologist at Cleveland Clinic, shared a post by Pavlos Msaouel, Medical…
Mar 7, 2024, 17:22 | Insight
Mohammad Jad Moussa: The new EVP 'fissure' challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Feb 16, 2024, 17:48 | Blog
Mohammad Jad Moussa: "La Crème de La Crème" panel discussing wealthy outcomes from the UNITE study
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, recently shared…
Nov 15, 2023, 17:32 | Insight
Omar Alhalabi: Have you treated bladder cancer with a component of "neuroendocrine" or "small cell" carcinoma?
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, posted on Twitter. "Have you…
Sep 10, 2023, 17:24 | Blog
Omar Alhalabi: Grateful to Nizar Tannir, MD Anderson Cancer Center for the opportunity to contribute to the one and only Holland-Frei Cancer Medicine book pub collaboratively with American Association for Cancer Research.
Jun 7, 2023, 10:49 | Drugs
Ph3 data is eagerly anticipated - Omar Alhalabi
Beautiful balanced discussion of the buzzing field of Bladder Cancer by Bourlon Maite from INCMNSZMX.…
All: 20 Posts: 1 - 100
Special Coverage